Shinya Neri

2.2k citations

36 papers · 1.7k indexed · h-index 19

Impact in

Oncology top 2%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism

Papers in

Oncology 27
- Cancer Cells and Metastasis 16
- Lymphatic System and Diseases 8
- Cancer Immunotherapy and Biomarkers 5
Cancer Research 8
- Cancer, Hypoxia, and Metabolism 3
- Breast Cancer Treatment Studies 3

Co-authors: Genichiro Ishii Atsushi Ochiai Steven H. Lin Amrish Sharma Wen Jiang Yifan Wang Weiye Deng Kanji Nagai
Journals: Journal of Cancer Research and Clinical Oncology (6 papers)Scientific Reports (3 papers)Lung Cancer (3 papers)Cancer Research (3 papers)Journal of Thoracic Oncology (2 papers)
Partner nations: Japan United States Germany

In The Last Decade

Shinya Neri

35 papers receiving 1.7k citations

Peers

Countries citing papers authored by Shinya Neri

Since Specialization

Citations

This map shows the geographic impact of Shinya Neri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shinya Neri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shinya Neri more than expected).

Fields of papers citing papers by Shinya Neri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shinya Neri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shinya Neri. The network helps show where Shinya Neri may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Shinya Neri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Shinya Neri Line = papers co-authored together Shinya Neri links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Relationship between podoplanin-expressing cancer-associated fibroblasts and the immune microenvironment of early lung squamous cell carcinoma Lung Cancer ·Jun Suzuki, Keiju Aokage, Shinya Neri, Takashi Sakai, Hiroko Hashimoto, M. Rouprêt, Adriano T. Mastrodomenico, Hiroshi Nakamura, Kenta Tane, Tomohiro Miyoshi, Masato Sugano, Motohiro Kojima, Satoshi Fujii, Takeshi Kuwata, Atsushi Ochiai, Masahiro Tsuboi, Genichiro Ishii	2020	62
2	Author Correction: Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome Scientific Reports ·Bhanu Prasad Venkatesulu, Amrish Sharma, Julianne Pollard‐Larkin, R Sadagopan, Jessica L. Symons, Shinya Neri, Pankaj K. Singh, Ramesh Tailor, Steven H. Lin, Sunil Krishnan	2020	7
3	An Improved Patient-Derived Xenograft Humanized Mouse Model for Evaluation of Lung Cancer Immune Responses Cancer Immunology Research ·Ismail M. Meraz, Mourad Majidi, Feng Meng, Arthur Kampf, Min Jin Ha, Shinya Neri, Bingliang Fang, Steven H. Lin, Peggy T. Tinkey, Elizabeth J. Shpall, Jeffrey S. Morris, Jack A. Roth	2019	108
4	Tankyrase disrupts metabolic homeostasis and promotes tumorigenesis by inhibiting LKB1-AMPK signalling Nature Communications ·Nan Li, Yifan Wang, Shinya Neri, Yuanli Zhen, StephenL. Wolfe, Yawei Qiao, Xu Li, Zhen Chen, Clifford Stephan, Weiye Deng, Rui Ye, Wen Jiang, Shuxing Zhang, Yonghao Yu, Mien‐Chie Hung, Junjie Chen, Steven H. Lin	2019	73
5	Ultra high dose rate (35 Gy/sec) radiation does not spare the normal tissue in cardiac and splenic models of lymphopenia and gastrointestinal syndrome Scientific Reports ·Bhanu Prasad Venkatesulu, Amrish Sharma, Julianne Pollard‐Larkin, R Sadagopan, Jessica L. Symons, Shinya Neri, Pankaj K. Singh, Ramesh Tailor, Steven H. Lin, Sunil Krishnan	2019	96
6	Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma Lung Cancer ·Takashi Sakai, Keiju Aokage, Shinya Neri, Hiroshi Nakamura, Shogo Nomura, Kenta Tane, Tomohiro Miyoshi, Masato Sugano, Motohiro Kojima, Satoshi Fujii, Takeshi Kuwata, Atsushi Ochiai, Akira Iyoda, Masahiro Tsuboi, Genichiro Ishii	2018	46
7	Immunosuppressive tumor microenvironment of usual interstitial pneumonia-associated squamous cell carcinoma of the lung Journal of Cancer Research and Clinical Oncology ·Takuya Ueda, Keiju Aokage, Hiroyoshi Nishikawa, Shinya Neri, Hiroshi Nakamura, Masato Sugano, Kenta Tane, Tomohiro Miyoshi, Motohiro Kojima, Satoshi Fujii, Takeshi Kuwata, Atsushi Ochiai, Masahiko Kusumoto, Kenji Suzuki, Masahiro Tsuboi, Genichiro Ishii	2018	9
8	Spatiotemporal characteristics of fibroblasts-dependent cancer cell invasion Journal of Cancer Research and Clinical Oncology ·Tomoyuki Miyashita, Sebastián T. Román, Hiroshi Nakamura, Masato Sugano, Shinya Neri, Satoshi Fujii, Hiroko Hashimoto, Masahiro Tsuboi, Atsushi Ochiai, Genichiro Ishii	2018	5
9	Prognostic impact of microscopic vessel invasion and visceral pleural invasion and their correlations with epithelial–mesenchymal transition, cancer stemness, and treatment failure in lung adenocarcinoma Lung Cancer ·Shinya Neri, Toshi Menju, Terumasa Sowa, Yojiro Yutaka, Daisuke Nakajima, Masatsugu Hamaji, Akihiro Ohsumi, Toyofumi F. Chen‐Yoshikawa, Toshihiko Satō, Makoto Sonobe, Akihiko Yoshizawa, Hironori Haga, Hiroshi Date	2018	20
10	Combining Immunotherapy and Radiotherapy for Cancer Treatment: Current Challenges and Future Directions Frontiers in Pharmacology ·Yifan Wang, Weiye Deng, Nan Li, Shinya Neri, Amrish Sharma, Wen Jiang, Steven H. Lin	2018	290
11	CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors Scientific Reports ·Masayuki Ishibashi, Shinya Neri, Hiroko Hashimoto, Tomoyuki Miyashita, Tatsuya Yoshida, Yuka Nakamura, Hibiki Udagawa, Keisuke Kirita, Shingo Matsumoto, Shigeki Umemura, Kiyotaka Yoh, Seiji Niho, Masahiro Tsuboi, Kenkichi Masutomi, Kōichi Goto, Atsushi Ochiai, Genichiro Ishii	2017	44
12	Fibroblast-led cancer cell invasion is activated by epithelial–mesenchymal transition through platelet-derived growth factor BB secretion of lung adenocarcinoma Cancer Letters ·Shinya Neri, Tomoyuki Miyashita, Hiroko Hashimoto, Yoshitaka Suda, Masayuki Ishibashi, 程亞鵬, L Pedetsen, Takeshi Kuwata, Masahiro Tsuboi, Kōichi Goto, Toshi Menju, Makoto Sonobe, Hiroshi Date, Atsushi Ochiai, Genichiro Ishii	2017	49
13	Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment Advanced Drug Delivery Reviews ·Genichiro Ishii, Atsushi Ochiai, Shinya Neri	2015	362
14	Cancer cell invasion driven by extracellular matrix remodeling is dependent on the properties of cancer-associated fibroblasts Journal of Cancer Research and Clinical Oncology ·Shinya Neri, Hiroko Hashimoto, 程亞鵬, L Pedetsen, Kenkichi Masutomi, Takeshi Kuwata, Hiroshi Date, Masahiro Tsuboi, Kōichi Goto, Atsushi Ochiai, Genichiro Ishii	2015	33
15	Podoplanin-Positive Cancer-Associated Fibroblasts in the Tumor Microenvironment Induce Primary Resistance to EGFR-TKIs in Lung Adenocarcinoma with EGFR Mutation Clinical Cancer Research ·Tatsuya Yoshida, Genichiro Ishii, Kōichi Goto, Shinya Neri, Hiroko Hashimoto, Kiyotaka Yoh, Seiji Niho, Shigeki Umemura, Shingo Matsumoto, Hironobu Ohmatsu, Shinsuke Iida, Akio Niimi, Kanji Nagai, Yuichiro Ohe, Atsushi Ochiai	2014	102
16	Ezrin-expressing lung adenocarcinoma cells and podoplanin-positive fibroblasts form a malignant microenvironment Journal of Cancer Research and Clinical Oncology ·Shigeki Suzuki, Genichiro Ishii, Poonam Doiphode, Shinya Neri, Hiroko Hashimoto, Chisako Yamauchi, Keiju Aokage, Tomoyuki Hishida, Junji Yoshida, Mitsutomo Kohno, Kanji Nagai, Atsushi Ochiai	2014	15
17	Prognostic Impact of Microscopic Vessel Invasion and Visceral Pleural Invasion in Non–Small Cell Lung Cancer Annals of Surgery ·Shinya Neri, Junji Yoshida, Genichiro Ishii, Yuki Matsumura, Keiju Aokage, Tomoyuki Hishida, Kanji Nagai	2014	47
18	Multiple Perivascular Epithelioid Cell Tumors: Clear Cell Tumor of the Lung Accompanied by Angiomyolipoma of the Liver Annals of Thoracic and Cardiovascular Surgery ·Shinya Neri, Genichiro Ishii, Keiju Aokage, Tomoyuki Hishida, Junji Yoshida, Mitsuyo Nishimura, Kanji Nagai	2013	6
19	Malignant Melanoma of the Lung: Report of Two Cases Annals of Thoracic and Cardiovascular Surgery ·Shinya Neri, Teruya Komatsu, Jiro Kitamura, Kyoko Otsuka, Nobuyuki Katakami, Yutaka Takahashi	2011	12
20	Surgical Treatment of Local Recurrence After Stereotactic Body Radiotherapy for Primary and Metastatic Lung Cancers Journal of Thoracic Oncology ·Shinya Neri, Yutaka Takahashi, M. A. Kleshchev, Hiroshi Hamakawa, Keisuke Tomii, Nobuyuki Katakami, Masaki Kokubo	2010	50

About Shinya Neri

Shinya Neri is a scholar working on Oncology, Cancer Research, Immunology and Allergy, Immunology and Pulmonary and Respiratory Medicine, having authored 36 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (16 papers), Lymphatic System and Diseases (8 papers), Lung Cancer Treatments and Mutations (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Lung Cancer Diagnosis and Treatment (5 papers), Immunotherapy and Immune Responses (4 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Breast Cancer Treatment Studies (3 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (366 citations), Immunology (341 citations), Pulmonary and Respiratory Medicine (525 citations) and Radiation (119 citations). Shinya Neri has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Genichiro Ishii, Atsushi Ochiai, Steven H. Lin, Amrish Sharma, Wen Jiang, Yifan Wang, Weiye Deng, Kanji Nagai, Hiroko Hashimoto and Nan Li. Their work appears in journals such as Journal of Cancer Research and Clinical Oncology, Scientific Reports, Lung Cancer, Cancer Research and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact